Venture capital investment in biopharmaceutical companies during the second quarter brought another set of staggering numbers, with 257 firms raising $8.9bn – the second highest quarterly dollar total going back to 2006, according to data from Pitchbook and the National Venture Capital Association’s Venture Monitor report released on 14 July.
Q2 was second only to the first quarter of 2021, when $11.4bn was invested in 339 biopharma ventures (revised from...






